Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholera | 111 | 2024 | 754 | 15.440 |
Why?
|
Vibrio cholerae O1 | 50 | 2024 | 243 | 7.650 |
Why?
|
Cholera Vaccines | 39 | 2024 | 264 | 7.600 |
Why?
|
Vibrio cholerae | 45 | 2023 | 793 | 6.940 |
Why?
|
Antibodies, Bacterial | 60 | 2024 | 1477 | 4.480 |
Why?
|
O Antigens | 20 | 2024 | 196 | 3.490 |
Why?
|
Immunologic Memory | 23 | 2022 | 1377 | 2.250 |
Why?
|
Bangladesh | 62 | 2023 | 742 | 2.240 |
Why?
|
Klebsiella Infections | 2 | 2024 | 146 | 1.650 |
Why?
|
Feces | 15 | 2024 | 1508 | 1.600 |
Why?
|
Cholera Toxin | 26 | 2024 | 562 | 1.600 |
Why?
|
Antigens, Bacterial | 16 | 2019 | 1148 | 1.590 |
Why?
|
Immunoglobulin A | 39 | 2024 | 992 | 1.550 |
Why?
|
B-Lymphocytes | 21 | 2022 | 4787 | 1.470 |
Why?
|
Vibrio cholerae O139 | 11 | 2023 | 54 | 1.410 |
Why?
|
Lipopolysaccharides | 17 | 2023 | 2217 | 1.320 |
Why?
|
Typhoid Fever | 11 | 2022 | 195 | 1.300 |
Why?
|
Haiti | 20 | 2024 | 553 | 1.220 |
Why?
|
Salmonella typhi | 12 | 2022 | 200 | 1.160 |
Why?
|
Immunity, Mucosal | 6 | 2020 | 499 | 1.120 |
Why?
|
Diarrhea | 16 | 2024 | 1319 | 1.070 |
Why?
|
Immunoglobulin G | 47 | 2024 | 4560 | 1.060 |
Why?
|
Antibody-Producing Cells | 8 | 2021 | 140 | 1.040 |
Why?
|
Klebsiella pneumoniae | 2 | 2024 | 253 | 0.990 |
Why?
|
Vaccination | 20 | 2024 | 3434 | 0.990 |
Why?
|
Immunity, Innate | 5 | 2019 | 3076 | 0.980 |
Why?
|
Serotyping | 4 | 2024 | 331 | 0.960 |
Why?
|
Chlorine | 1 | 2024 | 55 | 0.930 |
Why?
|
Administration, Oral | 23 | 2023 | 4026 | 0.880 |
Why?
|
Vaccines, Inactivated | 13 | 2023 | 186 | 0.830 |
Why?
|
Bacteremia | 7 | 2024 | 983 | 0.810 |
Why?
|
Fimbriae Proteins | 5 | 2017 | 133 | 0.720 |
Why?
|
Microbial Interactions | 2 | 2021 | 74 | 0.700 |
Why?
|
Immunoglobulin M | 21 | 2024 | 1527 | 0.690 |
Why?
|
Duodenum | 5 | 2022 | 495 | 0.680 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.670 |
Why?
|
Fluid Therapy | 3 | 2012 | 587 | 0.630 |
Why?
|
Family Characteristics | 8 | 2018 | 1002 | 0.570 |
Why?
|
Disease Outbreaks | 11 | 2022 | 1761 | 0.570 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 393 | 0.550 |
Why?
|
Vaccines, Attenuated | 5 | 2018 | 314 | 0.540 |
Why?
|
Adaptive Immunity | 1 | 2021 | 733 | 0.540 |
Why?
|
Vaccines, Conjugate | 8 | 2021 | 334 | 0.530 |
Why?
|
Antibody Formation | 9 | 2024 | 1392 | 0.520 |
Why?
|
Convalescence | 2 | 2021 | 107 | 0.520 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1466 | 0.510 |
Why?
|
Blood Group Antigens | 3 | 2023 | 183 | 0.510 |
Why?
|
Molecular Typing | 2 | 2015 | 115 | 0.490 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.480 |
Why?
|
Bacterial Typing Techniques | 2 | 2014 | 263 | 0.470 |
Why?
|
Cross Infection | 1 | 2024 | 1426 | 0.470 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 505 | 0.410 |
Why?
|
Immunity | 1 | 2018 | 1002 | 0.410 |
Why?
|
Paratyphoid Fever | 3 | 2022 | 34 | 0.400 |
Why?
|
Anti-Bacterial Agents | 10 | 2024 | 7469 | 0.390 |
Why?
|
Enterotoxigenic Escherichia coli | 4 | 2017 | 32 | 0.390 |
Why?
|
Blood | 2 | 2011 | 596 | 0.380 |
Why?
|
Humans | 144 | 2024 | 767040 | 0.370 |
Why?
|
Child, Preschool | 42 | 2024 | 42606 | 0.370 |
Why?
|
Neuraminidase | 3 | 2022 | 192 | 0.360 |
Why?
|
Escherichia coli Infections | 4 | 2017 | 518 | 0.360 |
Why?
|
Antibodies, Viral | 8 | 2023 | 3212 | 0.360 |
Why?
|
Sanitation | 1 | 2010 | 83 | 0.350 |
Why?
|
Disease Susceptibility | 4 | 2021 | 1791 | 0.340 |
Why?
|
Monocytes | 1 | 2019 | 2598 | 0.340 |
Why?
|
Bacterial Proteins | 9 | 2014 | 3834 | 0.340 |
Why?
|
Sepsis | 1 | 2024 | 2605 | 0.330 |
Why?
|
Family Health | 3 | 2018 | 1254 | 0.330 |
Why?
|
Adult | 74 | 2024 | 223317 | 0.330 |
Why?
|
Water Supply | 1 | 2010 | 204 | 0.330 |
Why?
|
Young Adult | 45 | 2021 | 59980 | 0.320 |
Why?
|
Genome, Bacterial | 5 | 2024 | 796 | 0.320 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.320 |
Why?
|
Helminthiasis | 1 | 2009 | 81 | 0.300 |
Why?
|
Blood Bactericidal Activity | 6 | 2015 | 124 | 0.300 |
Why?
|
Adolescent | 53 | 2024 | 89046 | 0.290 |
Why?
|
Lung Diseases, Fungal | 1 | 2008 | 123 | 0.290 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2008 | 175 | 0.280 |
Why?
|
Salmonella paratyphi A | 4 | 2022 | 47 | 0.280 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2017 | 126 | 0.280 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 9245 | 0.280 |
Why?
|
Child | 45 | 2024 | 80771 | 0.270 |
Why?
|
Mucous Membrane | 4 | 2019 | 659 | 0.270 |
Why?
|
Aspergillosis | 1 | 2008 | 241 | 0.260 |
Why?
|
Serologic Tests | 2 | 2019 | 382 | 0.260 |
Why?
|
Gastrointestinal Tract | 3 | 2024 | 837 | 0.260 |
Why?
|
Immunity, Humoral | 2 | 2020 | 610 | 0.250 |
Why?
|
Intestinal Mucosa | 4 | 2022 | 3043 | 0.250 |
Why?
|
Male | 69 | 2024 | 364203 | 0.240 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2538 | 0.240 |
Why?
|
Dehydration | 3 | 2011 | 216 | 0.230 |
Why?
|
Female | 72 | 2024 | 396660 | 0.230 |
Why?
|
Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
Water Purification | 1 | 2024 | 61 | 0.230 |
Why?
|
Carrier State | 2 | 2020 | 529 | 0.220 |
Why?
|
Signal Transduction | 2 | 2018 | 23621 | 0.210 |
Why?
|
Infant | 20 | 2024 | 36485 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 4 | 2018 | 1814 | 0.200 |
Why?
|
Phylogeny | 5 | 2024 | 2840 | 0.200 |
Why?
|
Enterobacteriaceae Infections | 1 | 2023 | 190 | 0.190 |
Why?
|
Seroepidemiologic Studies | 5 | 2023 | 404 | 0.190 |
Why?
|
Communicable Diseases, Emerging | 1 | 2022 | 149 | 0.180 |
Why?
|
Immunization Schedule | 2 | 2020 | 228 | 0.180 |
Why?
|
Parasitic Diseases | 1 | 2021 | 76 | 0.180 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
Escherichia coli | 4 | 2023 | 4209 | 0.180 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2020 | 40 | 0.180 |
Why?
|
Peroxidase | 2 | 2021 | 610 | 0.170 |
Why?
|
Contact Tracing | 2 | 2014 | 274 | 0.170 |
Why?
|
Middle Aged | 43 | 2022 | 223233 | 0.170 |
Why?
|
Bacteriophages | 3 | 2014 | 382 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4405 | 0.170 |
Why?
|
Metagenomics | 2 | 2021 | 473 | 0.160 |
Why?
|
Travel | 2 | 2023 | 805 | 0.160 |
Why?
|
Cross Reactions | 2 | 2020 | 828 | 0.160 |
Why?
|
Chromatography, Affinity | 2 | 2017 | 524 | 0.150 |
Why?
|
Cohort Studies | 13 | 2022 | 41718 | 0.150 |
Why?
|
Cytokines | 5 | 2019 | 7446 | 0.150 |
Why?
|
Desiccation | 1 | 2018 | 77 | 0.150 |
Why?
|
Gene Expression Profiling | 7 | 2018 | 9532 | 0.140 |
Why?
|
Enterotoxins | 2 | 2016 | 366 | 0.140 |
Why?
|
Th1 Cells | 3 | 2012 | 1040 | 0.140 |
Why?
|
Lymphocytes | 3 | 2022 | 2605 | 0.140 |
Why?
|
Proteomics | 4 | 2016 | 3913 | 0.140 |
Why?
|
Genetic Variation | 3 | 2024 | 6611 | 0.140 |
Why?
|
Epidemics | 2 | 2014 | 516 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 673 | 0.140 |
Why?
|
Th2 Cells | 3 | 2012 | 1077 | 0.130 |
Why?
|
Proteins | 1 | 2011 | 6001 | 0.130 |
Why?
|
Pneumonia | 1 | 2008 | 2159 | 0.130 |
Why?
|
Salmonella enterica | 1 | 2016 | 75 | 0.130 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 238 | 0.130 |
Why?
|
Hospitals | 4 | 2020 | 3883 | 0.130 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2227 | 0.130 |
Why?
|
Microbial Viability | 2 | 2015 | 236 | 0.130 |
Why?
|
Mass Vaccination | 1 | 2017 | 111 | 0.130 |
Why?
|
HLA-DR Antigens | 1 | 2017 | 609 | 0.130 |
Why?
|
Age Distribution | 2 | 2014 | 2870 | 0.130 |
Why?
|
DNA Probes | 1 | 2016 | 541 | 0.120 |
Why?
|
Tetanus Toxin | 1 | 2015 | 46 | 0.120 |
Why?
|
Interferon-gamma | 3 | 2014 | 3154 | 0.120 |
Why?
|
Integrin beta Chains | 1 | 2015 | 115 | 0.120 |
Why?
|
Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.120 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 59 | 0.120 |
Why?
|
T-Lymphocytes | 5 | 2015 | 10254 | 0.120 |
Why?
|
Magnetite Nanoparticles | 1 | 2016 | 310 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 583 | 0.120 |
Why?
|
Calgranulin A | 1 | 2015 | 81 | 0.120 |
Why?
|
Biopsy | 2 | 2018 | 6777 | 0.120 |
Why?
|
Immunization, Secondary | 4 | 2021 | 373 | 0.110 |
Why?
|
Time Factors | 7 | 2019 | 40154 | 0.110 |
Why?
|
Erythromycin | 2 | 2010 | 114 | 0.110 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 381 | 0.110 |
Why?
|
Antibody Specificity | 2 | 2021 | 1062 | 0.110 |
Why?
|
Bacterial Load | 1 | 2014 | 155 | 0.110 |
Why?
|
Bacterial Toxins | 2 | 2016 | 922 | 0.110 |
Why?
|
Disease Models, Animal | 8 | 2021 | 18330 | 0.110 |
Why?
|
Th17 Cells | 3 | 2022 | 790 | 0.110 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 976 | 0.110 |
Why?
|
Tetracycline | 2 | 2010 | 216 | 0.110 |
Why?
|
Specimen Handling | 1 | 2018 | 706 | 0.110 |
Why?
|
RNA, Bacterial | 2 | 2011 | 393 | 0.100 |
Why?
|
Hot Temperature | 1 | 2019 | 1441 | 0.100 |
Why?
|
Biliary Tract | 1 | 2013 | 136 | 0.100 |
Why?
|
Inflammasomes | 2 | 2015 | 540 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1205 | 0.100 |
Why?
|
Placebos | 1 | 2017 | 1660 | 0.100 |
Why?
|
Escherichia coli Proteins | 2 | 2016 | 1055 | 0.100 |
Why?
|
DNA, Bacterial | 2 | 2014 | 1477 | 0.100 |
Why?
|
Rural Population | 3 | 2017 | 2321 | 0.100 |
Why?
|
Intestinal Diseases | 1 | 2016 | 505 | 0.100 |
Why?
|
Genomics | 3 | 2024 | 5924 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 3 | 2017 | 1854 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 615 | 0.090 |
Why?
|
beta-Lactamases | 2 | 2023 | 307 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 588 | 0.090 |
Why?
|
Proteome | 2 | 2013 | 1890 | 0.090 |
Why?
|
Plant Extracts | 1 | 2014 | 496 | 0.090 |
Why?
|
Paneth Cells | 1 | 2011 | 100 | 0.090 |
Why?
|
Adenoviridae Infections | 1 | 2011 | 96 | 0.090 |
Why?
|
Rehydration Solutions | 1 | 2010 | 43 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2022 | 15925 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 11923 | 0.090 |
Why?
|
Antitoxins | 3 | 2019 | 75 | 0.090 |
Why?
|
Virulence | 4 | 2022 | 1294 | 0.090 |
Why?
|
Caribbean Region | 1 | 2010 | 193 | 0.090 |
Why?
|
Computer Simulation | 3 | 2019 | 6260 | 0.090 |
Why?
|
Azithromycin | 1 | 2011 | 201 | 0.080 |
Why?
|
Oligosaccharides | 1 | 2012 | 406 | 0.080 |
Why?
|
Minisatellite Repeats | 1 | 2010 | 162 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2024 | 5345 | 0.080 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2011 | 292 | 0.080 |
Why?
|
Lung | 1 | 2008 | 10076 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7868 | 0.080 |
Why?
|
Latin America | 1 | 2010 | 416 | 0.080 |
Why?
|
RNA, Messenger | 6 | 2023 | 12793 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12069 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2586 | 0.080 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.080 |
Why?
|
Program Evaluation | 1 | 2017 | 2505 | 0.080 |
Why?
|
Doxycycline | 1 | 2010 | 348 | 0.080 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 80 | 0.080 |
Why?
|
Floods | 1 | 2008 | 42 | 0.080 |
Why?
|
Serum | 1 | 2009 | 206 | 0.080 |
Why?
|
Metagenome | 2 | 2023 | 464 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1068 | 0.080 |
Why?
|
Fimbriae, Bacterial | 2 | 2005 | 138 | 0.080 |
Why?
|
HIV Infections | 1 | 2015 | 17542 | 0.080 |
Why?
|
Vitamin A | 2 | 2008 | 611 | 0.080 |
Why?
|
Aspergillus | 1 | 2008 | 94 | 0.080 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 1085 | 0.070 |
Why?
|
Vomiting | 1 | 2011 | 655 | 0.070 |
Why?
|
Malnutrition | 1 | 2014 | 632 | 0.070 |
Why?
|
Administration, Cutaneous | 3 | 2020 | 715 | 0.070 |
Why?
|
Case-Control Studies | 7 | 2023 | 22254 | 0.070 |
Why?
|
Rotavirus | 1 | 2008 | 110 | 0.070 |
Why?
|
Mice | 13 | 2022 | 81912 | 0.070 |
Why?
|
Rectum | 2 | 2009 | 898 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2013 | 5891 | 0.070 |
Why?
|
Zinc | 2 | 2008 | 675 | 0.070 |
Why?
|
Autoantigens | 1 | 2011 | 890 | 0.070 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 348 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1599 | 0.070 |
Why?
|
Genes, Bacterial | 1 | 2010 | 1076 | 0.070 |
Why?
|
Animals | 17 | 2022 | 168965 | 0.070 |
Why?
|
Asia | 2 | 2018 | 629 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3804 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2018 | 12451 | 0.060 |
Why?
|
Biological Products | 1 | 2014 | 948 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1804 | 0.060 |
Why?
|
Risk Factors | 8 | 2023 | 74886 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2024 | 26396 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 856 | 0.060 |
Why?
|
Tuberculosis | 1 | 1997 | 2011 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12986 | 0.060 |
Why?
|
World Health Organization | 1 | 2010 | 1327 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 4 | 2013 | 18063 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 1531 | 0.060 |
Why?
|
Public Health | 2 | 2023 | 2681 | 0.060 |
Why?
|
Pandemics | 4 | 2023 | 8736 | 0.060 |
Why?
|
Biofilms | 2 | 2022 | 641 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7236 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2023 | 2353 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2008 | 1836 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5499 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2009 | 1560 | 0.050 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 1137 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2015 | 2183 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2276 | 0.050 |
Why?
|
Immunoassay | 1 | 2006 | 744 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4855 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1240 | 0.050 |
Why?
|
Logistic Models | 3 | 2017 | 13284 | 0.050 |
Why?
|
Intestines | 2 | 2015 | 1905 | 0.050 |
Why?
|
Enterobacteriaceae | 1 | 2023 | 161 | 0.050 |
Why?
|
Salmonella | 1 | 2022 | 125 | 0.050 |
Why?
|
Disease Transmission, Infectious | 1 | 2007 | 560 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3618 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 158 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 2 | 2020 | 582 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2008 | 836 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7871 | 0.050 |
Why?
|
Agglutination | 1 | 2020 | 42 | 0.050 |
Why?
|
Animals, Suckling | 1 | 2020 | 69 | 0.050 |
Why?
|
Incidence | 4 | 2019 | 21526 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2021 | 340 | 0.050 |
Why?
|
Fever | 1 | 2008 | 1605 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14672 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 831 | 0.040 |
Why?
|
Aged | 8 | 2024 | 171319 | 0.040 |
Why?
|
Disasters | 1 | 2006 | 521 | 0.040 |
Why?
|
Rivers | 2 | 2013 | 65 | 0.040 |
Why?
|
Colony Count, Microbial | 2 | 2012 | 325 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 425 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2008 | 2592 | 0.040 |
Why?
|
Massachusetts | 2 | 2023 | 8890 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9513 | 0.040 |
Why?
|
Endotoxins | 1 | 2021 | 519 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 751 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2022 | 994 | 0.040 |
Why?
|
Sudan | 1 | 2018 | 86 | 0.040 |
Why?
|
Leishmania infantum | 1 | 1997 | 17 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9360 | 0.040 |
Why?
|
Pacific Islands | 1 | 1997 | 52 | 0.040 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11063 | 0.040 |
Why?
|
Age Factors | 4 | 2021 | 18401 | 0.040 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.040 |
Why?
|
Biological Evolution | 2 | 2014 | 1075 | 0.040 |
Why?
|
Odds Ratio | 2 | 2009 | 9660 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2008 | 1911 | 0.040 |
Why?
|
Immunization | 2 | 2015 | 1218 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6975 | 0.030 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 148 | 0.030 |
Why?
|
Dog Diseases | 1 | 1997 | 143 | 0.030 |
Why?
|
CD40 Ligand | 1 | 2018 | 528 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20169 | 0.030 |
Why?
|
Leishmaniasis, Visceral | 1 | 1997 | 98 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6067 | 0.030 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.030 |
Why?
|
Urban Population | 1 | 2004 | 2044 | 0.030 |
Why?
|
Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
North America | 1 | 2019 | 1287 | 0.030 |
Why?
|
Africa | 1 | 2018 | 725 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14766 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2016 | 6507 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 166 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26325 | 0.030 |
Why?
|
Prospective Studies | 5 | 2023 | 54886 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2014 | 2677 | 0.030 |
Why?
|
Virus Diseases | 1 | 2021 | 722 | 0.030 |
Why?
|
Bacteria | 2 | 2021 | 2212 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1639 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3232 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 85 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2017 | 853 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2014 | 118 | 0.030 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 663 | 0.030 |
Why?
|
Micronutrients | 1 | 2016 | 390 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1326 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 774 | 0.030 |
Why?
|
Language | 1 | 2023 | 1550 | 0.030 |
Why?
|
Prophages | 1 | 2013 | 39 | 0.030 |
Why?
|
Genotype | 3 | 2015 | 13035 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2419 | 0.030 |
Why?
|
Dominican Republic | 1 | 2012 | 78 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1628 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2268 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3385 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1591 | 0.030 |
Why?
|
Nepal | 1 | 2013 | 301 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4780 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2013 | 398 | 0.020 |
Why?
|
Family | 2 | 2015 | 3210 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2013 | 18989 | 0.020 |
Why?
|
Pedigree | 2 | 2009 | 4539 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6287 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2016 | 1182 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 2011 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39317 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 685 | 0.020 |
Why?
|
History, 18th Century | 1 | 2010 | 206 | 0.020 |
Why?
|
Intestine, Small | 2 | 2007 | 1217 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2010 | 4616 | 0.020 |
Why?
|
Food | 1 | 2014 | 766 | 0.020 |
Why?
|
Fresh Water | 1 | 2009 | 82 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7210 | 0.020 |
Why?
|
Bronchiolitis Obliterans | 1 | 2011 | 221 | 0.020 |
Why?
|
Zimbabwe | 1 | 2009 | 135 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1893 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3779 | 0.020 |
Why?
|
Models, Biological | 2 | 2019 | 9464 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2013 | 877 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10815 | 0.020 |
Why?
|
United States | 3 | 2023 | 72971 | 0.020 |
Why?
|
Rabbits | 1 | 2014 | 4751 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 751 | 0.020 |
Why?
|
Bacteriolysis | 1 | 2007 | 51 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 240 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1989 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 400 | 0.020 |
Why?
|
Adenoviridae | 1 | 2011 | 1092 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2009 | 391 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 998 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3684 | 0.020 |
Why?
|
Serum Bactericidal Test | 1 | 2005 | 3 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2014 | 1474 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2412 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15424 | 0.010 |
Why?
|
Bacterial Capsules | 1 | 2005 | 247 | 0.010 |
Why?
|
Mucins | 1 | 2007 | 569 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 1996 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4572 | 0.010 |
Why?
|
Self Report | 1 | 2015 | 3773 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3797 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1969 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2201 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17608 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1765 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 65295 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2722 | 0.010 |
Why?
|
Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
Multigene Family | 1 | 2005 | 1081 | 0.010 |
Why?
|
Virulence Factors | 1 | 2005 | 498 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3621 | 0.010 |
Why?
|
Drug Design | 1 | 2006 | 1045 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 4648 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81659 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29963 | 0.010 |
Why?
|
Risk Assessment | 2 | 2011 | 24299 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2726 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5785 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59548 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10092 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6893 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5796 | 0.010 |
Why?
|
Mutation | 2 | 2014 | 30211 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4348 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1997 | 123 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9612 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9606 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10455 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12158 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2009 | 4546 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 8068 | 0.010 |
Why?
|
Brazil | 1 | 1997 | 1250 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 30238 | 0.010 |
Why?
|
Dogs | 1 | 1997 | 3834 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15851 | 0.010 |
Why?
|
Aging | 1 | 2008 | 8729 | 0.010 |
Why?
|